Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma	B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 2	2026-06-25		NCT06544785

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
PETHEMA Foundation	21

19 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Complexo Hospitalario Universitario de Vigo (CHUVI)	Vigo	Spain	1
H Clínico Universitario Valencia	Valencia	Spain	1
H. Clínic de Barcelona	Barcelona	Spain	3
H. Clínico Univ. de Navarra	Pamplona	Spain	2
H. Clínico Univ. de Salamanca	Salamanca	Spain	2
H. General Univ. de Alicante	Alicante	Spain	2
H. Son Espases	Palma de Mallorca	Spain	2
H. Vall d' Hebron	Barcelona	Spain	1
Hospital Costa del Sol	Marbella	Spain	2
Hospital de Vigo	Vigo	Spain	1
Hospital del Mar	Barcelona	Spain	46
Hospital Infanta Leonor	Madrid	Spain	6
Hospital Marqués de Valdecilla	Santander	Spain	3
Hospital Regional Universitario de Málaga	Málaga	Spain	13
Hospital Santa Creu i Sant Pau	Barcelona	Spain	2
Hospital Universitario Central De Asturias	Oviedo	Spain	25
Hospital Universitario de Gran Canaria Doctor Negrín	Las Palmas de Gran Canaria	Spain	3
Hospital Universitario Reina Sofía	Córdoba	Spain	18
Hospital Universitario Virgen de Valme	Seville	Spain	12